- PTAB · Oct 15, 2025 · PGR2025-00002 · APJ Frederick C Laney · PGR · Adverse judgment
After Patent Owner disclaimed claims 1–78, the Board granted its motion for adverse judgment and terminated the post-grant review.
RulingsAdverse judgment- Adverse judgmentAdverse judgmentGranted
“Under our rules, “[a] party may request judgment against itself at any time during a proceeding,” which includes “[c]ancellation or disclaimer of a claim such that the party has no remaining claim in the trial.” 37 C.F.R. § 42.73(b)(2). See Arthrex, Inc. v. Smith & Nephew, Inc., 880 F.3d 1345, 1350 (Fed. Cir. 2018) (“there is no claim remaining for trial . . . when, as here, all of the challenged claims have been cancelled”). Thus, actions construed to be a request for adverse judgment include cancellation of patent claims such that a party has no remaining claim in the trial. 37 C.F.R. § 42.73(b)(2). Because Patent Owner has disclaimed all challenged claims such that no claims remain in the trial, we grant Patent Owner’s Motion to Terminate by Adverse Judgment.” slip op. at 2
NonePatents in suitUS 12,134,952 - Apple Inc. / Google LLC v. Spacetime3d, Inc.All claims unpatentablePTAB · Jul 2, 2024 · IPR2023-00344 · APJ Sheila F Mcshane · IPR · Final written decision
Claims 1–20 are unpatentable as obvious over the listed combinations of Anthony, Hanggie, Matthews, and Robertson.
RulingsFinal written decision- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“The Board instituted an inter partes review of the challenged claims pursuant to 35 U.S.C. § 314. Paper 11 (“Dec.”). We joined Google LLC as a party to the proceeding (collectively, with Apple Inc., “Petitioner”) based on a petition and motion for joinder filed in IPR2023-00578. Paper 14.” slip op. at 2
- PTAB / AIA Trials › Joinder §315(c) / SAS all-or-nothingJoinder, grantedGranted
“1 Google LLC, which filed a petition in IPR2023-00578, has been joined as a petitioner in this proceeding. See Paper 14, 8.” slip op. at 1
- Claim Construction › Intrinsic evidence (Phillips canons) › Plain and ordinary meaning to a POSITATerm construed board ownDecided for petitioner
“1. “3D space” and “two-dimensional (2D) space” The parties agree that the claim terms “3D space” and “two-” slip op. at 12
- Obviousness (§103) › Motivation to combine / reasonable expectation of successUnpatentableMotivation foundUnpatentable
“use of items in 2D space and difficulties in finding files, this argument is based on Anthony’s prior art discussion offered to identify the need for improvements that are solved by its 3D invention. See Ex. 1007 ¶¶ 6, 8. But the issue identified as the problem with 2D items, that is, difficulties in finding 2D files, is not at issue in the combination of the prior art that Petitioner proposes. As discussed, in the combination that Petitioner asserts, with the selection of a maximize button on a 3D window, the window would be displayed in 2D and would occupy all or most parts of the screen—so in that combination, difficulties in finding the 2D files would not be an issue. Pet. 57 (citing Ex. 1003 ¶ 111). Further, Petitioner offers the advantages that this presentation in 2D space would conserve power and allow certain users to interact with an application in a 2D environment. Ex. 1003 ¶¶ 66, 69. Accordingly, we credit Dr. Fuchs’s testimony that Petitioner’s proposed “specific experience [of the combination] would not deter a user from replacing images in 3D space with an object in 2D space.” Ex. 1033 ¶ 48. We also do not find persuasive Patent Owner’s argument that Anthony’s approach is different from the claimed invention because its method for” slip op. at 65
Patent outcomesUS 9,696,868 unpatentableClaim construction§ 103 obviousnesscites KSR · GrahamPatents in suitUS 9,696,868 - Parse Biosciences, Inc. v. 10x Genomics, Inc.Rehearing grantedPTAB · Feb 5, 2024 · IPR2023-00958 · APJ Michael J Fitzpatrick · IPR · Rehearing
Rehearing was granted and IPR instituted on claims 1–28 because the petition showed a reasonable likelihood that claim 1 was obvious over Linnarsson, McCloskey, and ordinary skill.
RulingsRehearing decision- RehearingRehearing, grantedGranted
“III. WHETHER REHEARING IS WARRANTED Petitioner argues that we misconstrued the claims “as requiring one to add tags in a way that can provide a distinction based on a ‘polynucleotide sequence.’” Req. 6 (quoting Dec. 14 (Petitioner’s emphasis)). Petitioner is correct. More specifically, we implicitly construed the claim language reciting “a second tag sequence distinguishing said sample polynucleotide from other sample polynucleotides from said cell,” as requiring said “distinguishing” to be based on the sequences of the sample polynucleotides. See, e.g., Dec. 14 (“[E]ach strand of cDNA that is tagged in Linnarsson is tagged regardless of the polynucleotide sequence of the cDNA or its corresponding mRNA. Thus, Linnarsson’s tags do not distinguish between ‘sample polynucleotides,’ whether cDNA or mRNA, of different sequences.”). Based on that misunderstanding, we erroneously determined that the proposed modification could not achieve the claim language, stating the following: Petitioner’s proposal appears to defeat satisfaction of another portion of claim 1, namely a “second tag sequence distinguishing said sample polynucleotide from other sample polynucleotides from said cell.” Ex. 1001, 30:62–64. For if the second tag is “added to the CDS or TSO after extension,” as opposed to the sample polynucleotide, as Petitioner argues (Pet. 39 (emphasis added)), it would appear that the second tag would be incapable of distinguishing any sample polynucleotide from other sample polynucleotides. Rather, the second tag would be ligated to each and every extension product bearing a CDS or TSO without regard to the sequence of any sample polynucleotide. Dec. 16. We now reconsider whether to institute.” slip op. at 2
- PTAB / AIA Trials › Discretionary denial › §325(d) same art / argumentsDecided for petitioner
“Cited”). Because we find that the same or substantially the same art was previously presented to the Office, we proceed to part two of the analysis. 2. Advanced Bionics Part Two Patent Owner argues that the Petition “fails to show any error in the Examiner’s application during prosecution of the prior art teachings Petitioner now purports to invoke from . . . McCloskey.” Prelim Resp. 23; see also id. at 24–25 (“Revisiting the same art and arguments already overcome during prosecution is a waste of the Board’s limited resources and would unfairly burden PO.”). However, Petitioner argued that “the Examiner committed major error in Examination by erroneously stating that the prior art fails to teach a dual tagging approach when, in fact, this approach is plainly taught in both McCloskey and McCloskey II.” Pet. 67. The record supports Petitioner’s position, and we agree that the error was material to patentability. See Ex. 1005, 131 (Notice of Allowance). Accordingly, and having considered all of the Becton, Dickinson factors, we do not exercise discretionary denial.” slip op. at 12
- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“We are persuaded there is a reasonable likelihood that Petitioner would prevail in demonstrating that a person of ordinary skill in the art would have had a reasonable expectation of success in combining the teachings of Linnarsson and McCloskey with the knowledge of a person of ordinary skill in the art to obtain the claimed subject matter. 8. Conclusion as to Claim 1 There is a reasonable likelihood that Petitioner would prevail in proving that claim 1 is unpatentable.” slip op. at 21
- Obviousness (§103) › Analogous artNot reached
“the three references is analogous art to the ’013 patent as opposed to each other. Prelim. Resp. 46 (citing Pet. 35; Sanofi-Aventis Deutschland GmbH v. Mylan Pharms. Inc., 66 F.4th 1373, 1374 (Fed. Cir. 2023)). As Sanofi- Aventis holds, a petitioner bears the burden of persuasion to establish that an asserted prior art reference is analogous art to the claimed invention. See Sanofi-Aventis, 66 F.4th at 1377 (“We agree with [the patent owner] that [the petitioner] did not carry its burden to argue that de Gennes is analogous to the [challenged] patent.”); id. (“In evaluating whether a reference is analogous, we have consistently held that a patent challenger must compare the reference to the challenged patent.”); id. at 1378–79 (“We have routinely held that the petitioner has the burden of proving unpatentability.”). However, the Petition should not be denied for failing to state explicitly that the cited prior art references are analogous art to the ’013 patent. Rather, as Sanofi-Aventis further held: “A petitioner is not required to anticipate and raise analogous art arguments in its petition; instead a petitioner can use its reply to ‘respond to arguments raised in the corresponding opposition, patent owner preliminary response, patent owner response, or decision on institution.’” Sanofi-Aventis, 66 F.4th at 1379 (quoting 37 C.F.R. § 42.23). Accordingly, we need not address this issue for purposes of deciding whether to institute trial.” slip op. at 15
§ 103 obviousnessDiscretionary denialPatents in suitUS 10,697,013 - Parse Biosciences, Inc. v. 10x Genomics, Inc.Rehearing grantedPTAB · Feb 5, 2024 · IPR2023-00955 · APJ Michael J Fitzpatrick · IPR · Rehearing
Rehearing granted and IPR instituted on claims 1–26; the Board found a reasonable likelihood that claim 1 would have been obvious over Linnarsson and McCloskey.
RulingsRehearing decision- RehearingRehearing, grantedGranted
“III. WHETHER REHEARING IS WARRANTED Petitioner argues that we misconstrued the claims “as requiring one to add tags in a way that can ‘provide a distinction based on a polynucleotide’s sequence.’” Req. 6 (quoting Dec. 15 (Petitioner’s emphasis)). Petitioner is correct. More specifically, we implicitly construed the claim language reciting “a second tag sequence distinguishing said sample polynucleotide from other sample polynucleotides from said cell,” as requiring said “distinguishing” to be based on the sequences of the sample polynucleotides. See, e.g., Dec. 14 (“[E]ach strand of cDNA that is tagged in Linnarsson is tagged regardless of the polynucleotide sequence of the cDNA or its corresponding mRNA. Thus, Linnarsson’s tags do not distinguish between ‘sample polynucleotides,’ whether cDNA or mRNA, of different sequences.”). Based on that misunderstanding, we denied the Petition because “adding a second tag sequence to Linnarsson’s CDS and/or TSO would do nothing to achieve such a distinction,” i.e., “a distinction based on a polynucleotide’s sequence.” Id. at 15. That was error. We now reconsider whether to institute.” slip op. at 2
- PTAB / AIA Trials › Discretionary denial › §325(d) same art / argumentsInstitution denied 325dDecided for petitioner
“the ’197 patent. See Ex. 1001, code (56) (listing McCloskey II under “References Cited”). Because we find that the same or substantially the same art was previously presented to the Office, we proceed to part two of the analysis.” slip op. at 11
- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“We are persuaded there is a reasonable likelihood that Petitioner would prevail in demonstrating that a person of ordinary skill in the art would have had a reasonable expectation of success in combining the teachings of Linnarsson and McCloskey to obtain the claimed subject matter. 6. Conclusion as to Claim 1 There is a reasonable likelihood that Petitioner would prevail in proving that claim 1 is unpatentable.” slip op. at 18
- Obviousness (§103) › Analogous artNot reached
“GmbH v. Mylan Pharms. Inc., 66 F.4th 1373, 1374 (Fed. Cir. 2023)). As Sanofi-Aventis holds, a petitioner bears the burden of persuasion to establish that an asserted prior art reference is analogous art to the claimed invention. See Sanofi-Aventis, 66 F.4th at 1377 (“We agree with [the patent owner] that [the petitioner] did not carry its burden to argue that de Gennes is analogous to the [challenged] patent.”); id. (“In evaluating whether a reference is analogous, we have consistently held that a patent challenger must compare the reference to the challenged patent.”); id. at 1378–79 (“We have routinely held that the petitioner has the burden of proving unpatentability.”). However, the Petition should not be denied for failing to state explicitly that the cited prior art references are analogous art to the ’197 patent. Rather, as Sanofi-Aventis further held: “A petitioner is not required to anticipate and raise analogous art arguments in its petition; instead a petitioner can use its reply to ‘respond to arguments raised in the corresponding opposition, patent owner preliminary response, patent owner response, or decision on institution.’” Sanofi-Aventis, 66 F.4th at 1379 (quoting 37 C.F.R. § 42.23). Accordingly, we need not address this issue for purposes of deciding whether to institute trial.” slip op. at 15
§ 103 obviousnessDiscretionary denialPatents in suitUS 10,240,197 - Unified Patents, LLC v. Intellectual Ventures II, LLCAll claims unpatentablePTAB · Aug 9, 2023 · IPR2022-00429 · APJ Matthew S Meyers · IPR · Final written decision
Claims 1–20 are unpatentable: claims 1–5, 7–12, and 14–20 over Chowdhary under §§ 102 and 103, and claims 1–20 over Chowdhary and Tobey under § 103.
RulingsFinal written decision- PTAB / AIA Trials › Real party in interest / privityDecided for petitioner
“On this record, we determine that we need not address whether Toyota was improperly excluded as an RPI because, “even if it were, it would not create a time bar or estoppel under 35 U.S.C. § 315.” See SharkNinja, Paper 11 at 18. Other than asserting that “estoppel provisions are implicated by this case” (PO Sur-reply 2311), there is no allegation or evidence that Toyota or any other RPI is barred or estopped from this proceeding, or that 11 Patent Owner asserts without explaining that the ’475 patent “is currently being asserted by Patent Owner against Toyota, as well as GM (another paying Member of Unified similarly situated to Toyota.). PO Sur-reply 23. However, the record indicates that the Toyota case has been dismissed and the GM case stayed. See Paper 32, 1 (Intellectual Ventures I LLC et al. v. Toyota Motor Corp. et al., 2:21-cv00389 (E.D. Tex. October 19, 2021) stipulated dismissal without prejudice on March 20, 2023); see also id. at 2 (Intellectual Ventures I LLC et al. v. General Motors Company, 6:21- cv01088 (W.D. Tex. October 19, 2021) (stayed pending settlement on April 6, 2023)). And, upon further inquiry, PACER Case Locator indicates that the GM case was dismissed in an order granting joint motion to dismiss entered on June 20, 2023. See GM case, Document 116. Petitioner purposefully omitted any other RPI to gain some advantage in our forum. See Unified Patent, LLC v. MemoryWeb, LLC, IPR2021-01413, Paper 76 at 5 (PTAB May 22, 2023) (Director Review Decision) (“The Board can and should make a determination of the real parties in interest or privity in any proceeding in which that determination may impact the underlying proceeding, for example, but not limited to, a time bar under 35 U.S.C. § 315(b) or an estoppel under 35 U.S.C. § 315(e) that might apply. That is not the situation here.”). Because we determine that neither the time bar nor estoppel provisions of 35 U.S.C. § 315 are implicated in this case, “we need not address whether [Toyota] is an unnamed RPI.” See Unified Patent, Paper 76 at 5 (“The Board should not have determined whether [there were additional] RPIs in this proceeding given that determination was not necessary to resolve the proceeding.”).” slip op. at 8
- Skill levelSkill level patent owner adoptedDecided for patent owner
“Petitioner asserts that at the time of the invention, one of ordinary skill in the art “would have had a bachelor’s degree in electrical engineering, computer science, computer engineering, physics, or a related subject, and two to three years of work experience in vehicle telematics.” Pet. 6–7 (citing Ex. 1002 ¶¶ 37–40). Petitioner asserts that “[a] lack of experience can be remedied with additional education (e.g., a Master’s degree), and likewise, a lack of education can be remedied with additional work experience (e.g., 5–6 years).” Id. Patent Owner essentially agrees with Petitioner’s assertion, but contends that the work experience should more broadly be in “mobile communications.” PO Resp. 16 (citing Ex. 2017 ¶ 27). In our Institution Decision, we determined that there was “not much difference between Petitioner’s and Patent Owner’s assertions, but noted that “we find that Patent Owner’s broader definition of a person of ordinary skill in the art is more consistent with the scope and content of the ’475 [p]atent.” Inst. Dec. 16–17 (citing Ex. 1001, 8:53–54; Ex. 1003, 3:15–18, Fig. 1). In its Reply, “Petitioner accepts the level of skill definition adopted in the Institution Decision,” and notes that “[n]either party contends that the differences in the proposed definitions affect the patentability of the challenged claims.” Pet. Reply 7. Based on this record, we apply Patent Owner’s definition of the level of skill, which also was applied in our Institution Decision, because it is consistent with the level of ordinary skill in the art at the time of the invention as reflected in the prior art of record. See Okajima, 261 F.3d at 1355.” slip op. at 12
- Claim Construction › Threshold & procedure › Whether a term needs construction (O2 Micro)Term construed board ownOther
“We begin our analysis by considering the language of the claims. At the outset, we note that none of independent claims 1, 8, and 15 require “actively notify[ing] the recipient soon after the violation,” as Patent Owner proposes. Independent claim 1 requires that if the computing device located within the vehicle determines that the vehicle committed a violation, the computing device located in the vehicle sends an indication of the violation to a remote computing system. Ex. 1001, 10:55–55. Independent claim 1 further recites “wherein the remote computing device is configured to notify a recipient about the violation committed by the vehicle.” Id. at 10:56–58. Independent claims 8 and 15 includes substantially similar limitations. Id. at 11:14–28, 12:11–25. Thus, the independent claims broadly recite “notify[ing] a recipient about the violation” without reference to any type, i.e., “active” or “passive,” or timing of the notification. Turning to dependent claims 4 and 5, claims 4 and 5 both begin by reciting “[t]he method of claim 1, wherein the remote computing device is configured to notify the recipient about the violation committed by the vehicle by.” Ex. 1001, 10:66–67:1, 11:3–5. Claim 4 further limits independent claim 1 “by permitting the recipient to view the indication of the violation via a browser” (id. at 10:67–11:2) and claim 5 further limits claim 1 “by sending a communication to the recipient in response to receiving the indication of the violation from the computing device” (id. at 11:4–6). Thus, we understand the recitation of “configured to notify a recipient” in claim 1 as being broad enough to cover both the notification recited in claim 4 that “permit[s] the recipient to view . . . via a browser” and the notification recited in claim 5 that “send[s] a communication to the recipient in response to receiving the indication of the violation from the computing device.” Id. at 10:66–11:7.” slip op. at 18
- Novelty / Anticipation (§102) › Anticipation standard (single reference, every element)UnpatentableUnpatentable
“At the outset, we agree with Petitioner that Patent Owner’s arguments are all premised upon its proposed construction of the phrase “configured to notify a recipient,” which, we do not adopt. See § III.C.1. As discussed above, we are not persuaded that the phrase “configured to notify a recipient,” as it appears in the context of claim 1, requires any type of active notification, as Patent Owner proposes. Consequently, Patent Owner’s argument that Chowdhary fails to teach the limitation at issue because Chowdhary “is wholly silent with regard to anything that is configured to actively notify someone about a violation” is unavailing. PO Resp. 24 (citing Ex. 2017 ¶ 57); see also id. at 27 (“[N]either the shortcuts to the reports shown in Figure 10 . . . or any other disclosure in Chowd[h]ary, actively notifies the fleet manager that a violation has been committed by the driver of the vehicle.”). Notwithstanding, to address this limitation, Petitioner directs us to Chowdhary’s disclosure that its “VSM application server automatically generates reports when new event data is received based on previously set criteria.” Id. (citing Ex. 1005 ¶¶ 7, 47–51, 96–97, 102–103, 114, Figs. 10–30; Ex. 1002 ¶¶ 84–87). Petitioner provides the following copy of Figure 10 of Chowdhary, annotated to identify, among several items, icon 1102 and icon 1104. Figure 10 illustrates “an example screen display for one embodiment of the VSM user interface” that includes “an ‘Alert/Notifications’ and ‘Messages’ screen.” Ex. 1005 ¶¶ 19, 97. Petitioner explains that Chowdhary discloses VSM application server receives speeding event data and prepares speeding reports based on the received event data. [Ex. 1005 ¶¶ 7, 47–51, 96–97, 114, Figs. 10–30]. An administrator sets alerts and/or notifications for reports that are of particular interest to the administrator so that an Alert/Notification is posted providing the title of the report (orange), the date/time the report was created (green), a link (via icon 1102, blue) to access the report each time a new speed limit violation report is created, and an icon 1104 (red) to remove reports so only new Alerts/Notifications are shown. [Ex. 1005 ¶¶ 97–98, 120, Fig. 10]. Pet. Reply 12–13. Relying on the deposition testimony of Mr. Wilson, Petitioner asserts that “Mr. Wilson testified that a clear notification would occur when a user logs in to a website, and there is an indication that a new message is available for the user to view.” Pet. Reply 13 (citing Ex. 2015,” slip op. at 32
Patent outcomesUS 9,291,475 unpatentableClaim construction§ 102 anticipation§ 103 obviousnesscites KSR · GrahamPatents in suitUS 9,291,475 - PTAB · Mar 16, 2023 · IPR2022-01391 · APJ Mitchell G Weatherly · IPR · Institution
The Board instituted IPR on claims 30–33, 35, 37–40, 43, 45–48, 51, 53, 54, 61, 62, 64, 65, 67, 69, 70, 72, and 75 on all petitioned grounds, and joined Samsung to IPR2022-01232.
RulingsInstitution decision- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“Institution of an inter partes review is authorized by statute when “the information presented in the petition filed under section 311 and any response filed under section 313 shows that there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” 35 U.S.C. § 314(a). For the reasons expressed below, we (1) institute inter partes review on the same grounds instituted in the Meta IPR, and (2) grant the Motion, subject to the conditions set forth below. B. Related Proceedings” slip op. at 3
- PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Denied
“We decline to exercise our discretion under Fintiv to deny institution of inter partes review. On June 21, 2022, the Director of the USPTO issued an Interim Procedure for Discretionary Denials in AIA Postgrant Proceedings with Parallel District Court Litigation, available at: https://www.uspto.gov/sites/default/files/documents/interim_proc_ discretionary_denials_aia_parallel_district_court_litigation_memo_ 20220621_.pdf (the “Interim Procedure”). The Interim Procedure provides that “the PTAB will not discretionarily deny institution of an IPR or PGR in view of parallel district court litigation where a petitioner stipulates not to pursue in a parallel district court proceeding the same grounds as in the petition or any grounds that could have reasonably been raised in the petition.” Interim Procedure 7. Here, Petitioner stipulates that it “will not pursue the grounds raised, or that reasonably could have been raised, in this IPR in the parallel litigation if IPR is instituted.” Pet. 9; Reply 1. We therefore adhere to the Interim Procedure in this Decision and decline to exercise our discretion to deny institution of inter partes review upon this basis.” slip op. at 7
- PTAB / AIA Trials › Joinder §315(c) / SAS all-or-nothingJoinder, grantedGranted
“Based on our review of the before us, we find that Petitioner demonstrates that allowing it to join the Meta IPR as a party will not materially lengthen the schedule, increase cost, or add to the complexity of briefing or discovery in the Meta IPR. Accordingly, we grant Petitioner’s Motion and add it as a party to the Meta IPR.” slip op. at 8
Discretionary denialPatents in suitUS 8,630,234 - PTAB · Mar 16, 2023 · IPR2022-01393 · APJ Terrence W Mcmillin · IPR · Institution
The Board instituted IPR on all challenged claims and grounds, and granted Samsung’s motion to join the Meta IPR as a petitioner.
RulingsInstitution decision- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“Institution of an inter partes review is authorized by statute when “the information presented in the petition filed under section 311 and any response filed under section 313 shows that there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” 35 U.S.C. § 314(a). For the reasons expressed below, we (1) institute inter partes review on the same grounds instituted in the Meta IPR, and (2) grant the Motion, subject to the conditions set forth below. B.” slip op. at 3
- PTAB / AIA Trials › Joinder §315(c) / SAS all-or-nothingJoinder, grantedGranted
“Here, Petitioner’s Motion requests no more than the statute allows. Petitioner represents that the current “Petition and the . . . Petition [in the Meta IPR] challenge the same claims, on the same grounds, and rely on the same prior art and evidence, including an identical declaration from the same expert.” Mot. 1. Furthermore, Petitioner agrees that, if joined as a party to the Meta IPR, “Petitioner will act as ‘understudy’ and will not assume an active role unless Meta ceases to participate” in the Meta IPR, “Meta will maintain the lead role in the proceeding so long as it is a party to the proceeding,” and “Petitioner will not seek additional depositions or deposition time.” Mot. 2.” slip op. at 5
- PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Decided for petitioner
“We decline to exercise our discretion under Fintiv to deny institution of inter partes review. On June 21, 2022, the Director of the USPTO issued an Interim Procedure for Discretionary Denials in AIA Postgrant Proceedings with Parallel District Court Litigation, available at: https://www.uspto.gov/sites/default/files/documents/interim_proc_ discretionary_denials_aia_parallel_district_court_litigation_memo_ 20220621_.pdf (the “Interim Procedure”). The Interim Procedure provides that “the PTAB will not discretionarily deny institution of an IPR or PGR in view of parallel district court litigation where a petitioner stipulates not to pursue in a parallel district court proceeding the same grounds as in the petition or any grounds that could have reasonably been raised in the petition.” Interim Procedure 7. Here, Petitioner stipulates that it will not pursue the grounds raised, or that reasonably could have been raised, in this IPR in the parallel litigation if IPR is instituted. Pet. 9; Reply 1. We therefore adhere to the Interim Procedure in this Decision and decline to exercise our discretion to deny institution of inter partes review upon this basis.” slip op. at 7
- Other 314aDecided for petitioner
“Patent Owner argues by implication that the Petition must set forth “compelling evidence of unpatentability” to avoid analysis of the Fintiv factors for deciding whether to exercise discretion to deny a petition. Opp. 13. Patent Owner’s argument is flawed for two reasons. First, as we discuss immediately above, even applying the Fintiv framework for deciding whether to discretionarily deny the Petition, we decline to exercise such discretion. Second, the Interim Procedure does not impose a requirement that a petition must always present compelling evidence of unpatentability to warrant institution. Rather, the Interim Procedure merely indicates that whenever a petitioner adduces compelling evidence of unpatentability, panels will not discretionarily deny the petition under Fintiv. Interim Procedure 2. D. Whether a Potential Denial of the Petition in the Meta IPR Justifies” slip op. at 8
Discretionary denialPatents in suitUS 10,880,721 - PTAB · Mar 16, 2023 · IPR2022-01392 · APJ Terrence W Mcmillin · IPR · Institution
The Board instituted IPR on claims 1, 2, 6, 9, 14, 15, 16, 20, 25, 34, 38, 39, 43, 45, 46, 49, 50, 135, 136, and 140 on all petitioned grounds, and granted joinder.
RulingsInstitution decision- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“Institution of an inter partes review is authorized by statute when “the information presented in the petition filed under section 311 and any response filed under section 313 shows that there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” 35 U.S.C. § 314(a). For the reasons expressed below, we (1) institute inter partes review on the same grounds instituted in the Meta IPR, and (2) grant the Motion, subject to the conditions set forth below. B.” slip op. at 3
- PTAB / AIA Trials › Joinder §315(c) / SAS all-or-nothingJoinder, grantedGranted
“If the Director institutes an inter partes review, the Director, in his or her discretion, may join as a party to that inter partes review any person who properly files a petition under section 311 that the Director, after receiving a preliminary response under section 313 or the expiration of the time for filing such a response, determines warrants the institution of an inter partes review under section 314. Section 315(c) “authorizes joinder of a person as a party, not ‘joinder’ of two proceedings” and “does not authorize the joined party to bring new issues from its new proceeding into the existing proceeding.” Facebook, Inc. v. Windy City Innovations, LLC, 973 F.3d 1321, 1335 (Fed. Cir. 2020). Here, Petitioner’s Motion requests no more than the statute allows. Petitioner represents that the current “Petition and the . . . Petition [in the Meta IPR] challenge the same claims, on the same grounds, and rely on the same prior art and evidence, including an identical declaration from the same expert.” Mot. 1. Furthermore, Petitioner agrees that, if joined as a party to the Meta IPR, “Petitioner will act as ‘understudy’ and will not assume an active role unless Meta ceases to participate” in the Meta IPR, “Meta will maintain the lead role in the proceeding so long as it is a party to the proceeding,” and “Petitioner will not seek additional depositions or deposition time.” Mot. 2.” slip op. at 5
- PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Decided for petitioner
“We decline to exercise our discretion under Fintiv to deny institution of inter partes review. On June 21, 2022, the Director of the USPTO issued an Interim Procedure for Discretionary Denials in AIA Postgrant Proceedings with Parallel District Court Litigation, available at: https://www.uspto.gov/sites/default/files/documents/interim_proc_ discretionary_denials_aia_parallel_district_court_litigation_memo_ 20220621_.pdf (the “Interim Procedure”). The Interim Procedure provides that “the PTAB will not discretionarily deny institution of an IPR or PGR in view of parallel district court litigation where a petitioner stipulates not to pursue in a parallel district court proceeding the same grounds as in the petition or any grounds that could have reasonably been raised in the petition.” Interim Procedure 7. Here, Petitioner stipulates that it will not pursue the grounds raised, or that reasonably could have been raised, in this IPR in the parallel litigation if IPR is instituted. Pet. 9; Reply 1. We therefore adhere to the Interim Procedure in this Decision and decline to exercise our discretion to deny institution of inter partes review upon this basis.” slip op. at 7
- Other 314aDecided for petitioner
“Patent Owner argues by implication that the Petition must set forth “compelling evidence of unpatentability” to avoid analysis of the Fintiv factors for deciding whether to exercise discretion to deny a petition. Opp. 13. Patent Owner’s argument is flawed for two reasons. First, as we discuss immediately above, even applying the Fintiv framework for deciding whether to discretionarily deny the Petition, we decline to exercise such discretion. Second, the Interim Procedure does not impose a requirement that a petition must always present compelling evidence of unpatentability to warrant institution. Rather, the Interim Procedure merely indicates that whenever a petitioner adduces compelling evidence of unpatentability, panels will not discretionarily deny the petition under Fintiv. Interim Procedure 2. D. Whether a Potential Denial of the Petition in the Meta IPR Justifies” slip op. at 8
Discretionary denialPatents in suitUS 10,880,721 - PTAB · Mar 16, 2023 · IPR2022-01390 · APJ Mitchell G Weatherly · IPR · Institution
The Board instituted inter partes review of claims 1–3, 6, 10, 11, 19–22, 24, 25, 28, and 29 on all petitioned grounds and granted Samsung’s motion to join the Meta IPR.
RulingsInstitution decision- PTAB / AIA Trials › Institution threshold (reasonable likelihood / more likely than not)InstitutedInstituted
“Institution of an inter partes review is authorized by statute when “the information presented in the petition filed under section 311 and any 1 The Leahy-Smith America Invents Act (“AIA”) included revisions to 35 U.S.C. §§ 102 and 103 that became effective March 16, 2013. Because the application for the ’234 patent was filed on July 28, 2009, we apply the pre-AIA versions of §§ 102, 103. 2 U.S. Patent No. 7,668,159 B2 (Ex. 1005, “Buckley”). 3 U.S. Patent No. 8,731,163 B1 (Ex. 1009, “Bates”). response filed under section 313 shows that there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” 35 U.S.C. § 314(a). For the reasons expressed below, we (1) institute inter partes review on the same grounds instituted in the Meta IPR, and (2) grant the Motion, subject to the conditions set forth below. B. Related Proceedings” slip op. at 2
- PTAB / AIA Trials › Discretionary denial › Fintiv (parallel litigation)Decided for petitioner
“Patent Owner argues that we should deny the Petition under Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 at 2–3 (PTAB Mar. 20, 2020) (precedential). Opp. 7–12. Patent Owner points to the Litigation. See supra Part I.B. We decline to exercise our discretion under Fintiv to deny institution of inter partes review. On June 21, 2022, the Director of the USPTO issued an Interim Procedure for Discretionary Denials in AIA Postgrant Proceedings with Parallel District Court Litigation, available at: https://www.uspto.gov/sites/default/files/documents/interim_proc_ discretionary_denials_aia_parallel_district_court_litigation_memo_ 20220621_.pdf (the “Interim Procedure”). The Interim Procedure provides that “the PTAB will not discretionarily deny institution of an IPR or PGR in view of parallel district court litigation where a petitioner stipulates not to pursue in a parallel district court proceeding the same grounds as in the petition or any grounds that could have reasonably been raised in the petition.” Interim Procedure 7. Here, Petitioner stipulates that it “will not pursue the grounds raised, or that reasonably could have been raised, in this IPR in the parallel litigation if IPR is instituted.” Pet. 9; Reply 1. We therefore adhere to the Interim Procedure in this Decision and decline to exercise our discretion to deny institution of inter partes review upon this basis.” slip op. at 7
- PTAB / AIA Trials › Joinder §315(c) / SAS all-or-nothingJoinder, grantedGranted
“Section 315(c) “authorizes joinder of a person as a party, not ‘joinder’ of two proceedings” and “does not authorize the joined party to bring new issues from its new proceeding into the existing proceeding.” Facebook, Inc. v. Windy City Innovations, LLC, 973 F.3d 1321, 1335 (Fed. Cir. 2020). Here, Petitioner’s Motion requests no more than the statute allows. Petitioner represents that the current “Petition and the . . . Petition [in the Meta IPR] challenge the same claims, on the same grounds, and rely on the same prior art and evidence, including an identical declaration from the same expert.” Mot. 1. Furthermore, Petitioner agrees that, if joined as a party to the Meta IPR, “Petitioner will act as ‘understudy’ and will not assume an active role unless Meta ceases to participate” in the Meta IPR, “Meta will maintain the lead role in the proceeding so long as it is a party to the proceeding,” and “Petitioner will not seek additional depositions or deposition time.” Mot. 2.” slip op. at 5
- Other 314aDecided for petitioner
“Patent Owner argues by implication that the Petition must set forth “compelling evidence of unpatentability” to avoid analysis of the Fintiv factors for deciding whether to exercise discretion to deny a petition. Opp. 13. Patent Owner’s argument is flawed for two reasons. First, as we discuss immediately above, even applying the Fintiv framework for deciding whether to discretionarily deny the Petition, we decline to exercise such discretion. Second, the Interim Procedure does not impose a requirement that a petition must always present compelling evidence of unpatentability to warrant institution. Rather, the Interim Procedure merely indicates that whenever a petitioner adduces compelling evidence of unpatentability, panels will not discretionarily deny the petition under Fintiv. Interim Procedure 2. D. Whether a Potential Denial of the Petition in the Meta IPR Justifies Denying the Petition in this Proceeding” slip op. at 8
Discretionary denialPatents in suitUS 8,630,234 - Dji Europe B.V. v. Textron Innovations Inc.Adverse judgmentPTAB · Feb 15, 2023 · IPR2022-00163 · APJ Scott A Daniels · IPR · Adverse judgment
The Board entered adverse judgment against the Patent Owner on claims 1–8, 10–13, and 15–25 after those claims were statutorily disclaimed.
RulingsAdverse judgment- Adverse judgmentAdverse judgmentGranted
“indicating that all challenged claims had been disclaimed, requesting adverse judgment under 37 C.F.R. § 42.73(b)(2), and entering the respective Disclaimer, dated November 16, 2022, into the record of this proceeding as Exhibit 2020. Paper 18. Patent Owner’s disclaimer of claims 1–8, 10–13, and 15–25 means that Patent Owner has no claims remaining in the present proceeding and adverse judgement is therefore appropriate. II. ORDER In consideration of the foregoing, it is hereby: ORDERED that adverse judgment is entered under 37 C.F.R. § 42.73(b) against Patent Owner with respect to claims 1–8, 10–13, and 15– 25 of the ’647 patent; and” slip op. at 2
NonePatents in suitUS 10,243,647
Holdings, summaries, rulings, issues, outcomes, winners and claim constructions shown for a decision were generated by a large language model reading the opinion. They are a guide to the decision, not the decision. Confirm every one against the court's own text before relying on it. Outcomes read from the patent owner’s side. Party names are extracted from the decision and are missing on about 900 short Director denials and scans, which carry the trial number instead.